NICE(NICE)
NICE
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $3.18B | $3.47B | $3.88B | $4.54B | $5.15B |
| Low | $3.11B | $3.37B | $3.68B | $4.45B | $5.04B |
| High | $3.19B | $3.55B | $4.00B | $4.62B | $5.24B |
| EBITDA Avg | $1.08B | $1.18B | $1.40B | $1.76B | $2.17B |
| Low | $1.07B | $1.14B | $1.37B | $1.71B | $2.12B |
| High | $1.09B | $1.23B | $1.43B | $1.79B | $2.22B |
| EBIT Avg | $902M | $1.02B | $1.25B | $1.61B | $2.02B |
| Low | $895M | $972M | $1.22B | $1.56B | $1.96B |
| High | $908M | $1.06B | $1.28B | $1.64B | $2.06B |
| Net Income Avg | $707M | $798M | $980M | $1.26B | $1.59B |
| Low | $701M | $762M | $956M | $1.23B | $1.54B |
| High | $712M | $833M | $1.00B | $1.29B | $1.62B |
| EPS Avg | $11.17 | $12.71 | $15.53 | $19.92 | $25.08 |
| Low | $11.07 | $12.04 | $15.10 | $19.37 | $24.38 |
| High | $11.24 | $13.16 | $15.86 | $20.35 | $25.62 |
| Analysts (Rev / EPS) | 12 / 8 | 12 / 8 | 8 / 6 | 6 / 5 | 6 / 5 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $787M | $845M | $837M | $849M | $863M | $925M | $922M | $937M |
| Low | $785M | $842M | $832M | $844M | $859M | $920M | $917M | $932M |
| High | $788M | $849M | $841M | $854M | $868M | $930M | $927M | $943M |
| EBITDA Avg | $271M | $291M | $284M | $286M | $296M | $321M | $322M | $330M |
| Low | $268M | $287M | $282M | $285M | $294M | $319M | $320M | $328M |
| High | $274M | $297M | $286M | $288M | $298M | $323M | $324M | $332M |
| EBIT Avg | $209M | $231M | $226M | $230M | $241M | $267M | $270M | $279M |
| Low | $206M | $228M | $224M | $229M | $239M | $265M | $268M | $277M |
| High | $212M | $237M | $228M | $232M | $243M | $269M | $272M | $281M |
| Net Income Avg | $165M | $182M | $178M | $181M | $190M | $210M | $212M | $220M |
| Low | $163M | $179M | $177M | $180M | $189M | $209M | $211M | $218M |
| High | $167M | $187M | $179M | $183M | $191M | $212M | $214M | $221M |
| EPS Avg | $2.78 | $3.07 | $3.00 | $3.05 | $3.20 | $3.54 | $3.58 | $3.70 |
| Low | $2.74 | $3.02 | $2.98 | $3.03 | $3.17 | $3.52 | $3.55 | $3.67 |
| High | $2.82 | $3.15 | $3.02 | $3.07 | $3.22 | $3.57 | $3.60 | $3.73 |
| Analysts (Rev / EPS) | 9 / 10 | 9 / 10 | 7 / 8 | 4 / 8 | 4 / 8 | 7 / 8 | 7 / 9 | 3 / 9 |